Frontera Therapeutics
PrivateLast Round
Series B
Jul 19, 2022
Total Funding Raised
$230M
Company Overview
Frontera Therapeutics is a biotechnology company that develops and commercializes recombinant adeno-associated virus (rAAV) gene therapies for the treatment of genetic disorders in ophthalmology, cardiology, and neurology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frontera Therapeutics Comparables
Compare Frontera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exegenesis Bio | 86% | |
| Belief BioMed Inc. | 83% | |
| Avirmax, Inc. | 80% | |
Frontera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 19, 2022 |
Frontera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyu Capital | Series B |
| Creacion Ventures | Series B, Series A |
| Starr Investment Holdings | Series B |
| OrbiMed | Series B, Series A |
| Starr Investments & Benefits | Series B |
| TMCP | Series B |
| HongShan Capital Group (HSG) | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2025
Will present gene therapy advances at the 2025 ASGCT Annual meeting.
- Apr 22, 2025
Will present gene therapy advances at the 2025 ARVO Annual meeting.
Frontera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Frontera Therapeutics's valuation, stock price, and market status.